Investigating cerebral vein thrombosis in Norway
Epidemiology, Clinical and Radiological Presentation and Long-term Prognosis of Cerebral Venous Thrombosis in a Norwegian Population (NoCVT)
This study looks at how common cerebral vein thrombosis is in Norway, what causes it, how it's treated, and what happens to patients in the long run.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Sex | All |
| Sponsor | University Hospital, Akershus Academic / other |
| Locations | 1 site (Lørenskog) |
| Trial ID | NCT05021198 on ClinicalTrials.gov |
What this trial studies
The Norwegian Cerebral Venous Thrombosis Study aims to explore the epidemiology, risk factors, diagnostics, treatment, and long-term prognosis of cerebral vein thrombosis (CVT) in a large Norwegian population exceeding 3 million. This observational study will utilize a combination of existing health registries and clinical databases, along with new prospectively collected clinical data, to conduct a comprehensive analysis of CVT cases diagnosed between 2014 and 2023. Data will be gathered from 13 hospitals across Norway, allowing for a thorough examination of clinical presentations, treatment outcomes, and long-term health impacts related to CVT.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with cerebral vein thrombosis between 2014 and 2023 at one of the participating hospitals.
Not a fit: Patients who do not have a diagnosis of cerebral vein thrombosis or were diagnosed outside the specified timeframe will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the management and outcomes of cerebral vein thrombosis, potentially improving patient care and treatment strategies.
How similar studies have performed: Other studies focusing on cerebral vein thrombosis have shown success in understanding its epidemiology and treatment outcomes, making this approach both relevant and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * A diagnosis of CVT 2014-2023 from the 13 participating primary hospitals Exclusion Criteria: * none
Where this trial is running
Lørenskog
- Akershus University Hospital — Lørenskog, Norway (Recruiting)
Study contacts
- Principal investigator: Espen Saxhaug Kristoffersen, MD, PhD — University Hospital, Akershus
- Study coordinator: Espen Saxhaug Kristoffersen, MD, PhD
- Email: e.s.kristoffersen@medisin.uio.no
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.